文献速递心力衰竭与心肌病

射血分数降低心衰无房颤患者卒中风险预测模型验证

Predicting stroke in heart failure and reduced ejection fraction without atrial fibrillation.
PubMed 文献 · Eur Heart J · 2022-01-01

在 PARADIGM-HF、ATMOSPHERE 和 DAPA-HF 三项试验的汇总患者水平队列中,验证了一个由卒中史、胰岛素治疗糖尿病和 NT-proBNP 水平三项变量组成的简易卒中风险模型。在 12 751 例基线无房颤的 HFrEF 患者中,中位随访 2.0 年期间 346 例(2.7%)发生卒中,风险随评分升高而增加,最高五分位卒中发生率与未抗凝房颤患者相似,模型区分度良好(C-index 0.84)。

要点

  • 无房颤 HFrEF 患者中卒中风险随简易评分升高而增加。
  • 最高五分位卒中发生率与未抗凝房颤患者相当。
  • 该模型或可识别可从预防性抗凝中获益的高危患者。

核心结论

  • 可识别出卒中风险与未抗凝房颤患者相当的無房颤 HFrEF 患者亚群,预防性抗凝的风险获益平衡可能合理,但需前瞻性验证。

研究设计与样本

  • 汇总 PARADIGM-HF、ATMOSPHERE 和 DAPA-HF 三项试验的患者水平队列,验证既往推导的简易卒中风险模型。
  • 共纳入 20 159 例患者,其中 12 751 例基线无房颤。

主要发现

  • 无房颤患者中 346 例(2.7%)发生卒中,中位随访 2.0 年,发生率为 11.7/1000 患者年。
  • 以第一五分位为参照,第四五分位风险比 2.35(95%CI 1.60-3.45),第五五分位风险比 3.73(95%CI 2.58-5.38)。
  • 最高五分位卒中发生率为 21.2/1000 患者年,与未抗凝房颤患者的 20.1/1000 患者年相似。
  • 模型区分度良好,C-index 为 0.84(95%CI 0.75-0.91)。

关键数值与推荐

  • 风险模型包含三个变量:既往卒中史、胰岛素治疗的糖尿病、血浆 N 末端 B 型利钠肽原水平。

临床怎么用

  • 对无房颤 HFrEF 患者可使用该简易评分识别卒中高危亚群,为个体化预防性抗凝决策提供参考。

局限性

  • 预防性抗凝用于高危无房颤 HFrEF 患者的假设需前瞻性试验验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Patients with heart failure with reduced ejection fraction (HFrEF) are at significant risk of stroke. Anticoagulation reduces this risk in patients with and without atrial fibrillation (AF), but the risk-to-benefit balance in the latter group, overall, is not favourable. Identification of patients with HFrEF, without AF, at the highest risk of stroke may allow targeted and safer use of prophylactic anticoagulant therapy. METHODS AND RESULTS: In a pooled patient-level cohort of the PARADIGM-HF, ATMOSPHERE, and DAPA-HF trials, a previously derived simple risk model for stroke, consisting of three variables (history of prior stroke, insulin-treated diabetes, and plasma N-terminal pro-B-type natriuretic peptide level), was validated. Of the 20 159 patients included, 12 751 patients did not have AF at baseline. Among patients without AF, 346 (2.7%) experienced a stroke over a median follow up of 2.0 years (rate 11.7 per 1000 patient-years). The risk for stroke increased with increasing risk score: fourth quintile hazard ratio (HR) 2.35 [95% confidence interval (CI) 1.60-3.45]; fifth quintile HR 3.73 (95% CI 2.58-5.38), with the first quintile as reference. For patients in the top quintile, the rate of stroke was 21.2 per 1000 patient-years, similar to participants with AF not receiving anticoagulation (20.1 per 1000 patient-years). Model discrimination was good with a C-index of 0.84 (0.75-0.91). CONCLUSION: It is possible to identify a subset of HFrEF patients without AF with a stroke-risk equivalent to that of patients with AF who are not anticoagulated. In these patients, the risk-to-benefit balance might justify the use of prophylactic anticoagulation, but this hypothesis needs to be tested prospectively.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Kondo, Abdul-Rahim, Talebi, et al. Predicting stroke in heart failure and reduced ejection fraction without atrial fibrillation. Eur Heart J. 2022. PMID: 36017729. doi:10.1093/eurheartj/ehac487

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。